tiprankstipranks
Quest Diagnostics (DGX)
NYSE:DGX

Quest Diagnostics (DGX) Stock Price & Analysis

827 Followers

DGX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$117.60 - $145.62
Previous Close$141.28
Volume647.50K
Average Volume (3M)963.03K
Market Cap
$15.70B
Enterprise Value$20.49B
Total Cash (Recent Filing)$686.00M
Total Debt (Recent Filing)$5.37B
Price to Earnings (P/E)19.0
Beta0.58
Jul 24, 2024
Dividend Yield2.04%
Share Statistics
EPS (TTM)7.43
Shares Outstanding111,091,574
10 Day Avg. Volume927,436
30 Day Avg. Volume963,028
Standard Deviation0.09
R-Squared0.28
Alpha0.00241
Financial Highlights & Ratios
Price to Book (P/B)-6.06
Price to Sales (P/S)1.70
Price to Cash Flow (P/CF)7.50
P/FCF Ratio7.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.21
Enterprise Value/Gross Profit6.71
Enterprise Value/Ebitda17.57
Forecast
Price Target Upside2.77% Upside
Rating ConsensusHold
Number of Analyst Covering11

Bulls Say, Bears Say

Bulls Say
Financial PerformanceAnalyst reiterates a Buy rating and a $155 price target, recognizing the company's strong financial health and positive business trends.
Guidance UpdateThe company updated guidance, raising net revenue and adjusted EPS, reflecting management's confidence in the company's future performance.
Mergers And AcquisitionsThe company remains excited about the Haystack acquisition, which is expected to bring additional growth and enhance the company's market position.
Bears Say
Financial Performance2024 guidance was below expectations, with the upcoming period expected to be particularly weak.
Legislative ImpactThe Protecting Access to Medicare Act is the lingering concern that, if enacted, would significantly reduce revenue.
Regulatory ChallengesThe FDA's final proposed ruling regarding LDTs remains an overhang on the group despite management's readiness to tackle additional regulatory challenges.
---

Financials

Annual

Ownership Overview

1.78%31.40%43.98%22.84%
43.98% Other Institutional Investors
22.84% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

DGX FAQ

What was Quest Diagnostics’s price range in the past 12 months?
Quest Diagnostics lowest stock price was $117.60 and its highest was $145.62 in the past 12 months.
    What is Quest Diagnostics’s market cap?
    Currently, no data Available
    When is Quest Diagnostics’s upcoming earnings report date?
    Quest Diagnostics’s upcoming earnings report date is Jul 24, 2024 which is in 57 days.
      How were Quest Diagnostics’s earnings last quarter?
      Quest Diagnostics released its earnings results on Apr 23, 2024. The company reported $2.04 earnings per share for the quarter, beating the consensus estimate of $1.856 by $0.184.
        Is Quest Diagnostics overvalued?
        According to Wall Street analysts Quest Diagnostics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Quest Diagnostics pay dividends?
          Quest Diagnostics pays a Quarterly dividend of $0.75 which represents an annual dividend yield of 2.04%. See more information on Quest Diagnostics dividends here
            What is Quest Diagnostics’s EPS estimate?
            Quest Diagnostics’s EPS estimate is $2.34.
              How many shares outstanding does Quest Diagnostics have?
              Quest Diagnostics has 111,091,576 shares outstanding.
                What happened to Quest Diagnostics’s price movement after its last earnings report?
                Quest Diagnostics reported an EPS of $2.04 in its last earnings report, beating expectations of $1.856. Following the earnings report the stock price went up 5.081%.
                  Which hedge fund is a major shareholder of Quest Diagnostics?
                  Among the largest hedge funds holding Quest Diagnostics’s share is Davis Selected Advisers. It holds Quest Diagnostics’s shares valued at 317M.
                    ---

                    Company Description

                    Quest Diagnostics

                    Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
                    ---

                    DGX Earnings Call

                    Q1 2024
                    0:00 / 0:00
                    ---

                    DGX Revenue Breakdown

                    97.02%97.02%2.98%
                    97.02% Diagnostic Information Services
                    2.98% All other operating segments
                    tipranks
                    ---

                    DGX Stock 12 Month Forecast

                    Average Price Target

                    $145.20
                    ▲(2.77% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"121":"$121","156":"$156","129.75":"$129.8","138.5":"$138.5","147.25":"$147.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":155,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$155.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":145.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$145.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":136,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$136.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[121,129.75,138.5,147.25,156],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2023","6":"Nov<br/>2023","9":"Feb<br/>2024","12":"May<br/>2024","25":"May<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,137.38,138.73538461538462,140.09076923076924,141.44615384615383,142.80153846153846,144.15692307692308,145.5123076923077,146.8676923076923,148.22307692307692,149.57846153846154,150.93384615384616,152.28923076923076,153.64461538461538,{"y":155,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,137.38,137.98153846153846,138.58307692307693,139.18461538461537,139.78615384615384,140.3876923076923,140.98923076923077,141.5907692307692,142.19230769230768,142.79384615384615,143.39538461538461,143.99692307692305,144.59846153846152,{"y":145.2,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,137.38,137.27384615384614,137.1676923076923,137.06153846153845,136.95538461538462,136.84923076923076,136.74307692307693,136.63692307692307,136.53076923076924,136.42461538461538,136.31846153846155,136.2123076923077,136.10615384615386,{"y":136,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":130.87,"date":1685059200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":132.62,"date":1685664000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":135.99,"date":1688688000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":133.39,"date":1691107200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":128.35,"date":1693526400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":122.91,"date":1696550400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":132.45,"date":1698969600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":134.68,"date":1701388800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":140.43,"date":1704412800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":124.29,"date":1706832000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":123.97,"date":1709251200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":130.63,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":137.38,"date":1714694400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Laboratory
                    QuidelOrtho
                    NeoGenomics

                    Best Analysts Covering DGX

                    1 Year
                    Ann HynesMizuho Securities
                    1 Year Success Rate
                    25/37 ratings generated profit
                    68%
                    1 Year Average Return
                    +6.32%
                    reiterated a buy rating 15 days ago
                    Copying Ann Hynes's trades and holding each position for 1 Year would result in 67.57% of your transactions generating a profit, with an average return of +6.32% per trade.
                    Popular Stocks
                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis